| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/07/2002 | US20020028484 Expression vector for use in the treatment and prevention of viral diseases |
| 03/07/2002 | US20020028469 Generating monoclonal antibodies |
| 03/07/2002 | US20020028436 Suppression of leukocyte transferring in humans; administer immunoglobulins to humans, detect bound receptor, evaluate immune response |
| 03/07/2002 | US20020028215 Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same |
| 03/07/2002 | US20020028213 Vaccines and method therefor |
| 03/07/2002 | US20020028211 Broad spectrum pyrogenic exotoxins antagonists and vaccines |
| 03/07/2002 | US20020028210 Vaccine composition comprising helicobacter pylori flagellin polypeptide |
| 03/07/2002 | US20020028209 Treatment or prophylaxis of hepatitis, especially hepatitis B |
| 03/07/2002 | US20020028208 Nucleic acid encoding feline cd86 |
| 03/07/2002 | US20020028207 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 03/07/2002 | US20020028206 Method for enhancing immunogenicity of antigens |
| 03/07/2002 | US20020028205 May be comprised of a heavily glycosylated mucin part, which mediates binding to selectins, such as PSGL-1; absorber to prevent a hyperacute rejection of a xenotransplant |
| 03/07/2002 | US20020028203 T cell inhibitory receptor compositions and uses thereof |
| 03/07/2002 | US20020028202 Common gamma chain blocking agents |
| 03/07/2002 | US20020028200 Enhancing the production of antibodies which recognize and bind to FimH of uropathogenic Type-I-fimbriated Escherichia coli, but not to FimH of non-uropathogenic Type I- fimbriated Escherichia coli. |
| 03/07/2002 | US20020028195 Viruses for the treatment of cellular proliferative disorders |
| 03/07/2002 | US20020028178 Treating CD40+ malignancies comprising administering a therapeutically effective amount of an antibody or antibody fragment which binds to CD40L thereby inhibiting CD40/CD40L interaction or CD40 signaling. |
| 03/07/2002 | DE10041560A1 New peptide from the alpha1 adrenergic receptor, useful for diagnosis and treatment of psoriasis, and also for raising specific antibodies |
| 03/07/2002 | DE10041342A1 Preparing vaccine against cancer, useful for treatment or prevention, comprises coupling antibody mimetopes,selected from a phage-display library, to macromolecular carrier |
| 03/07/2002 | CA2705366A1 Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer |
| 03/07/2002 | CA2424052A1 Packaging of positive-strand rna virus replicon particles |
| 03/07/2002 | CA2421503A1 Methods and compositions for inhibiting angiogenesis |
| 03/07/2002 | CA2421055A1 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| 03/07/2002 | CA2420944A1 Inhibition of cmv infection and dissemination |
| 03/07/2002 | CA2420897A1 Chemoprotectant for gastric toxicity |
| 03/07/2002 | CA2420867A1 Methods for enhancing the efficacy of cancer therapy |
| 03/07/2002 | CA2420105A1 Human kinases |
| 03/07/2002 | CA2420103A1 Modulation of fas and fasl expression |
| 03/07/2002 | CA2420062A1 Erbb4 antagonists |
| 03/06/2002 | EP1184459A2 Manipulation of gene copy number in Bordetella |
| 03/06/2002 | EP1183386A1 Tm4sf receptors |
| 03/06/2002 | EP1183374A1 Recombinant fusion protein, (vaccine) composition containing the same and method for the production thereof |
| 03/06/2002 | EP1183368A2 Proteinfragmente die verschiedene epitope der hpv proteine e6 und e7 umfassen, ihre herstellung und verwendungen insbesondere zur impfung |
| 03/06/2002 | EP1183367A1 Cytotoxic t-cell epitopes of the papillomavirus l1-protein and use thereof in diagnostics and therapy |
| 03/06/2002 | EP1183364A1 Groel muteins with improved stability |
| 03/06/2002 | EP1183363A2 Methods for regulating protein conformation using molecular chaperones |
| 03/06/2002 | EP1183362A1 Il-1 eta dna and polypeptides |
| 03/06/2002 | EP1183351A1 Phospholipid transfer protein |
| 03/06/2002 | EP1183349A1 Tumor-associated antigen (c42) |
| 03/06/2002 | EP1183348A2 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| 03/06/2002 | EP1183344A2 Adam polynucleotides and polypeptides |
| 03/06/2002 | EP1183333A1 Methods of using rnase p reaction mechanisms of action |
| 03/06/2002 | EP1183332A1 Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142 |
| 03/06/2002 | EP1183275A2 Combined approach to treatment of cancer with hcg vaccines |
| 03/06/2002 | EP1183272A2 49 human secreted proteins |
| 03/06/2002 | EP1183269A1 Attenuated microorganisms for the treatment of infection |
| 03/06/2002 | EP1183268A1 LAWSONIA DERIVED GENE AND RELATED OmpH POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES |
| 03/06/2002 | EP1183231A1 Cytofectin dimers and methods of use thereof |
| 03/06/2002 | EP1183228A2 Esters of l-carnitine or alkanoyl l-carnitines |
| 03/06/2002 | EP1183049A2 Modification of biological elements |
| 03/06/2002 | EP1183047A2 Pharmaceutical preparation |
| 03/06/2002 | EP1183045A2 Stability, biocompatibility optimized adjuvant (sba) for enhancing humoral and cellular immune response |
| 03/06/2002 | EP1183044A2 Adjuvant combinations for immunization and vaccines |
| 03/06/2002 | EP1183040A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway |
| 03/06/2002 | EP1183036A1 Method for preparing dual virally inactivated immune globulin for intravenous administration |
| 03/06/2002 | EP0938505B1 Anti-endoglin monoclonal antibodies and their use in anti-angiogenesis therapy |
| 03/06/2002 | EP0703784B1 Release and mobilisation of haematopoietic cells |
| 03/06/2002 | EP0584201B1 Transmission-blocking vaccine against malaria |
| 03/06/2002 | CN1338947A Novel mucosal delivery system |
| 03/06/2002 | CN1338513A Recombinant adenovirus for preventing baby's diarrhea |
| 03/06/2002 | CN1338310A Epitope vaccine of hog cholera virus and its preparing process |
| 03/06/2002 | CN1338309A Synthetic peptide vaccine of hog cholera and its preparing process |
| 03/06/2002 | CN1338308A Synthetic peptide vaccine of influenzand its preparing process |
| 03/06/2002 | CN1338307A Epitope vaccine of influenza virus and its preparing process |
| 03/06/2002 | CN1338306A Genetically engineered pylorospirobacillus vaccine and its preparing process |
| 03/06/2002 | CN1080312C Rapamycin assay |
| 03/06/2002 | CN1080311C Peptide related to human programmed cell death and DNA cencoding it |
| 03/06/2002 | CN1080305C Preparation of hepatocellular cearcinoma oncogene |
| 03/06/2002 | CN1080304C Method for preparing modified L-protein for hepatitis B virus |
| 03/06/2002 | CN1080300C Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines |
| 03/06/2002 | CN1080299C Vaccinal efficacy augmentor and efficacy augmenting foods |
| 03/06/2002 | CN1080124C Pneumococcal polysaccharide conjugate vaccine |
| 03/05/2002 | US6353150 Chimeric mammals with human hematopoietic cells |
| 03/05/2002 | US6353093 gidB |
| 03/05/2002 | US6353092 Patched-2 polypeptide |
| 03/05/2002 | US6353089 Stimulating proliferation of cytotoxic lymphocytes cells by exposing a fluid sample with a major histocompatability complex and incubate to allow lysis of the presenting cells |
| 03/05/2002 | US6352975 Methods of treating hypertension and compositions for use therein |
| 03/05/2002 | US6352842 Exonucease-mediated gene assembly in directed evolution |
| 03/05/2002 | US6352832 Anti-CCR2 antibodies and methods of use therefor |
| 03/05/2002 | US6352722 Time-release agent comprising trehalose diisobutyrate hexaacetate and fluticasone; drug delivery |
| 03/05/2002 | US6352709 Introducing into patient a medical device of which at least a portion comprises one of a sydnonimine and a furoxan; anticoagulants |
| 03/05/2002 | US6352696 Viral capsomeres; vaccines; gene expression, genetic engineering |
| 03/05/2002 | US6352694 Immunotherapy; biochemical immobilization; genetic engineering; medical diagnosis |
| 03/05/2002 | CA2079463C Live vaccines |
| 02/28/2002 | WO2002016612A2 Genes and proteins, and their uses |
| 02/28/2002 | WO2002016611A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 02/28/2002 | WO2002016602A2 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | WO2002016598A2 Nucleic acid and corresponding protein named 158p1h4 useful in the treatment and detection of bladder and other cancers |
| 02/28/2002 | WO2002016595A2 Kidney-specific protein |
| 02/28/2002 | WO2002016593A2 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 02/28/2002 | WO2002016585A2 Imidazoline receptor homologs |
| 02/28/2002 | WO2002016560A1 Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells |
| 02/28/2002 | WO2002016549A2 METHODS OF TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDE |
| 02/28/2002 | WO2002016440A2 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections |
| 02/28/2002 | WO2002016436A2 ANTIBODIES TO HUMAN IL-1$g(b) |
| 02/28/2002 | WO2002016431A2 PEPTIDES OF THE α1-ADRENERGIC RECEPTOR AND THEIR USE FOR PSORIASIS |
| 02/28/2002 | WO2002016429A2 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | WO2002016422A2 Recombinant constructs of borrelia burgdorferi |
| 02/28/2002 | WO2002016421A2 Altered ospa of borrelia burgdorferi |
| 02/28/2002 | WO2002016420A2 Antiviral compounds derived from the hsv gd protein and methods |